Advanced Enzyme Technologies' Q4 FY 2025-26 Quarterly Results

Result Summary

• Advanced Enzyme Technologies Ltd reported a 16.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 19.7%.
• Its expenses for the quarter were up by 13.1% QoQ and 13.9% YoY.
• The net profit increased 4.8% QoQ and increased 69.3% YoY.
• The earnings per share (EPS) of Advanced Enzyme Technologies Ltd stood at 3.84 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Advanced Enzyme Technologies Ltd is a biotechnology company primarily engaged in the production and distribution of enzyme-based solutions. The company specializes in offering a wide range of enzymes used in various industries, including pharmaceuticals, nutraceuticals, food processing, and animal nutrition. Enzymes are biological catalysts that accelerate chemical reactions, and Advanced Enzyme Technologies provides these crucial components to enhance productivity and efficiency in diverse industrial applications. As of the latest available information, the company continues to expand its product portfolio and market presence. Any recent major developments specific to the company are not available.

Revenue

In the fourth quarter of the fiscal year 2026 (Q4FY26), Advanced Enzyme Technologies Ltd reported a total income of ₹210.60 crores. This represents a quarter-over-quarter (QoQ) increase of 16.7% from ₹180.42 crores in the third quarter of the same fiscal year (Q3FY26). Additionally, there was a year-over-year (YoY) growth of 19.7% compared to ₹175.92 crores in the fourth quarter of the previous fiscal year (Q4FY25). The reported revenue figures highlight the company's growth trajectory over both the short-term and long-term periods. The increase in total income across both QoQ and YoY metrics may reflect the company’s operational and market expansion within its industry.

Profitability

During Q4FY26, the company achieved a profit before tax (PBT) of ₹59.80 crores, marking a 2.6% increase from ₹58.29 crores reported in Q3FY26. Year-over-year, the PBT rose significantly by 37.6% from ₹43.46 crores in Q4FY25. The tax expense for Q4FY26 was ₹14.55 crores, which decreased by 3.7% QoQ from ₹15.11 crores in Q3FY26 and decreased by 13.0% YoY from ₹16.73 crores in Q4FY25. Consequently, the profit after tax (PAT) for Q4FY26 was ₹45.25 crores, showing a QoQ increase of 4.8% from ₹43.18 crores in Q3FY26 and a substantial YoY rise of 69.3% from ₹26.73 crores in Q4FY25. These figures illustrate the company's profitability improvements over the examined periods.

Operating Metrics

The earnings per share (EPS) for Advanced Enzyme Technologies Ltd in Q4FY26 was ₹3.84, which increased by 1.3% compared to ₹3.79 in Q3FY26. The YoY growth in EPS was noteworthy at 62.0%, rising from ₹2.37 in Q4FY25. This metric indicates the company's enhanced earnings performance per share over both the quarters and the year. The company's total expenses in Q4FY26 amounted to ₹150.90 crores, representing a 13.1% rise from ₹133.38 crores in Q3FY26, and an increase of 13.9% from ₹132.47 crores in Q4FY25. These changes in expenses indicate the cost dynamics associated with the company's operations over the observed periods, which align with its revenue and profitability movements.